home.social

#pulmonaryhypertension — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #pulmonaryhypertension, aggregated by home.social.

  1. DID YOU KNOW?
    🔹️25 million people suffer from PH in 🌎?
    🔹️3 in 4 pts have advanced dz by the time of dx
    🔹️cost of therapies $100k/yr
    #phaware #RareDiseaseDay #ShowYourStripes #ShareYourColours
    ---
    RT @PHAssociation
    More than 25 million people in the U.S. and 300 million people worldwide are impacted by a rare disease. #Pulmonaryhypertension is often associated with other #rarediseases such as #scleroderma, #HHT, idiopathic #pulmonary
    twitter.com/PHAssociation/stat

  2. DID YOU KNOW?
    🔹️25 million people suffer from PH in 🌎?
    🔹️3 in 4 pts have advanced dz by the time of dx
    🔹️cost of therapies $100k/yr
    #phaware #RareDiseaseDay #ShowYourStripes #ShareYourColours
    ---
    RT @PHAssociation
    More than 25 million people in the U.S. and 300 million people worldwide are impacted by a rare disease. #Pulmonaryhypertension is often associated with other #rarediseases such as #scleroderma, #HHT, idiopathic #pulmonary
    twitter.com/PHAssociation/stat

  3. DID YOU KNOW?
    🔹️25 million people suffer from PH in 🌎?
    🔹️3 in 4 pts have advanced dz by the time of dx
    🔹️cost of therapies $100k/yr
    #phaware #RareDiseaseDay #ShowYourStripes #ShareYourColours
    ---
    RT @PHAssociation
    More than 25 million people in the U.S. and 300 million people worldwide are impacted by a rare disease. #Pulmonaryhypertension is often associated with other #rarediseases such as #scleroderma, #HHT, idiopathic #pulmonary
    twitter.com/PHAssociation/stat

  4. DID YOU KNOW?
    🔹️25 million people suffer from PH in 🌎?
    🔹️3 in 4 pts have advanced dz by the time of dx
    🔹️cost of therapies $100k/yr
    #phaware #RareDiseaseDay #ShowYourStripes #ShareYourColours
    ---
    RT @PHAssociation
    More than 25 million people in the U.S. and 300 million people worldwide are impacted by a rare disease. #Pulmonaryhypertension is often associated with other #rarediseases such as #scleroderma, #HHT, idiopathic #pulmonary
    twitter.com/PHAssociation/stat

  5. DID YOU KNOW?
    🔹️25 million people suffer from PH in 🌎?
    🔹️3 in 4 pts have advanced dz by the time of dx
    🔹️cost of therapies $100k/yr
    #phaware #RareDiseaseDay #ShowYourStripes #ShareYourColours
    ---
    RT @PHAssociation
    More than 25 million people in the U.S. and 300 million people worldwide are impacted by a rare disease. #Pulmonaryhypertension is often associated with other #rarediseases such as #scleroderma, #HHT, idiopathic #pulmonary
    twitter.com/PHAssociation/stat

  6. Very exicted to share that our #PET #imaging paper in #PulmonaryHypertension #PAH is out: doi.org/10.1186/s12931-022-022
    Many thanks to our great team at @[email protected] @[email protected]

    CONCLUSIONS: Perfusion imaging during O2 + iNO showed a significant difference in the heterogeneity associated with the vertical gradient in perfusion, distinguishing in this small cohort study PAH subjects from controls.

    #lung #respiratory #research #pulmonary #perfusion #circulation #PETCT #PIBLabs

  7. Very exicted to share that our #PET #imaging paper in #PulmonaryHypertension #PAH is out: doi.org/10.1186/s12931-022-022
    Many thanks to our great team at @[email protected] @[email protected]

    CONCLUSIONS: Perfusion imaging during O2 + iNO showed a significant difference in the heterogeneity associated with the vertical gradient in perfusion, distinguishing in this small cohort study PAH subjects from controls.

    #lung #respiratory #research #pulmonary #perfusion #circulation #PETCT #PIBLabs

  8. Very exicted to share that our #PET #imaging paper in #PulmonaryHypertension #PAH is out: doi.org/10.1186/s12931-022-022
    Many thanks to our great team at @[email protected] @[email protected]

    CONCLUSIONS: Perfusion imaging during O2 + iNO showed a significant difference in the heterogeneity associated with the vertical gradient in perfusion, distinguishing in this small cohort study PAH subjects from controls.

    #lung #respiratory #research #pulmonary #perfusion #circulation #PETCT #PIBLabs

  9. Very exicted to share that our #PET #imaging paper in #PulmonaryHypertension #PAH is out: doi.org/10.1186/s12931-022-022
    Many thanks to our great team at @[email protected] @[email protected]

    CONCLUSIONS: Perfusion imaging during O2 + iNO showed a significant difference in the heterogeneity associated with the vertical gradient in perfusion, distinguishing in this small cohort study PAH subjects from controls.

    #lung #respiratory #research #pulmonary #perfusion #circulation #PETCT #PIBLabs

  10. Very exicted to share that our #PET #imaging paper in #PulmonaryHypertension #PAH is out: doi.org/10.1186/s12931-022-022
    Many thanks to our great team at @[email protected] @[email protected]

    CONCLUSIONS: Perfusion imaging during O2 + iNO showed a significant difference in the heterogeneity associated with the vertical gradient in perfusion, distinguishing in this small cohort study PAH subjects from controls.

    #lung #respiratory #research #pulmonary #perfusion #circulation #PETCT #PIBLabs

  11. #introduction

    I'm a physician-scientist at Brigham and Women's Hospital and Harvard Medical School. I study how metabolic reprogramming drives #pulmonaryfibrosis and #pulmonaryhypertension using #metabolomics. We believe in #openscience.

    I am a pulmonologist taking care of the #peoplesventricle in patients with #pulmonaryhypertension and critical illness.

    I am here for #science, #rstats, and #academicchatter.

    #fatherofdaughters (3) married to an amazing lawyer-turned-general contractor.